# Global Mortality from Severe Infectious Diseases Among Adolescents Aged 10–19 Years, 1990–2023: Long-Term Trends and Cause Composition from the Global Burden of Disease 2023 Study

## TL;DR

This study shows that severe infectious diseases still cause significant and unequal deaths among teenagers globally, with slower progress compared to younger children.

## Contribution

The study provides the first comprehensive global analysis of severe infectious disease mortality trends among adolescents aged 10–19 years using the Global Burden of Disease 2023 data.

## Key findings

- Mortality from severe infectious diseases declined more slowly among adolescents than younger children from 1990 to 2023.
- Adolescent mortality increased during the peak of the COVID-19 pandemic while declining in younger children.
- Lower respiratory infections and meningitis remain major contributors to adolescent mortality, especially in low-socioeconomic settings.

## Abstract

Background: Severe infectious diseases remain a preventable cause of adolescent mortality worldwide, yet global evidence focused on adolescence as a distinct life-course stage—and its vulnerability to health system disruption—remains limited. We examined long-term mortality rate trends, cause composition, and COVID-19–related changes among adolescents compared with late childhood. Methods: We analyzed Global Burden of Disease 2023 mortality estimates from 1990 to 2023 for six acute severe infectious causes: lower respiratory infections, meningitis, encephalitis, diarrhoeal diseases, typhoid/paratyphoid fever, and COVID-19. Analyses focused on adolescents aged 10–19 years, with children aged 5–9 years as a comparator. Mortality rates (per 100,000 population) were the primary metric. Trends were quantified using estimated annual percentage change (EAPC), and pre-COVID, COVID peak, and post-COVID periods were compared across Socio-demographic Index (SDI) categories. Results: From 1990 to 2023, mortality rates declined globally across all age groups; however, reductions among adolescents were consistently slower than those among children aged 5–9 years (EAPC −2.27% vs. −3.55% per year). Diarrhoeal diseases and typhoid/paratyphoid fever exhibited the steepest long-term declines, whereas lower respiratory infections and meningitis demonstrated slower reductions and maintained a substantial share of adolescent mortality risk. During the COVID-19 peak, mortality rates modestly increased among adolescents, while children continued their gradual decline. Mortality rates remained highest in low-SDI settings. Conclusions: Despite substantial global progress, severe infectious diseases continue to impose significant and inequitable mortality risk among adolescents. The persistence of a concentrated cause profile and the amplification of mortality during system disruption underscore adolescence as a vulnerable life-course stage requiring sustained prevention and resilient acute care systems.